Home › Guides › Pharmacy market exit

Pharmacy market exit — giving up your NHS contract

What community pharmacy owners need to know about voluntary removal from the pharmaceutical list and the alternatives to closure.

⚠ Important notice The information on this page is intended for general awareness only. It does not constitute professional advice and should not be acted upon without first consulting a qualified pharmacy applications consultant. Regulations change — always seek specialist guidance before taking any action. Contact TI Pharmacy Consultancy for advice specific to your situation.
In summary: Market exit is the process by which a community pharmacy voluntarily removes itself from the NHS pharmaceutical list — giving up its NHS contract. It is the opposite of market entry and is governed by the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 in England. Before taking any steps towards market exit, pharmacy owners should understand the regulatory requirements, the notice periods involved and the alternatives that may be available.

What is market exit?

Market exit refers to voluntary removal from the pharmaceutical list — the point at which a community pharmacy ceases to provide NHS pharmaceutical services and its contract with NHS England ends. Once a pharmacy has exited the market, its NHS contract is surrendered and cannot be recovered without going through the market entry process again.

Market exit is distinct from consolidation (where a contract is transferred to another existing site) and change of ownership (where the contract transfers to a new owner). Both consolidation and sale are generally preferable to outright market exit, as they preserve the commercial value of the NHS contract.

The notice period

A community pharmacy wishing to voluntarily remove itself from the pharmaceutical list must serve notice on PCSE and the relevant ICB. The regulations set out the required notice period, which is typically three months. The ICB uses this period to assess the impact of the closure on local pharmaceutical provision and to take steps to ensure that patients continue to have access to services.

In some circumstances — for example, where the pharmacy’s closure would leave a significant gap in provision — the ICB may seek to delay or manage the exit to protect patient access. TI Pharmacy Consultancy advises on how to manage this process and ensure that notifications are made correctly.

Before you give notice — consider the alternatives

Before serving notice of market exit, it is worth considering whether any of the following alternatives might be more appropriate:

  • Selling the pharmacy — the most commercially sensible route in most cases, as the NHS contract adds significant value to the business. A change of ownership application allows the contract to transfer to a buyer. Read more about change of ownership.
  • Consolidation — if you own more than one pharmacy, consolidating onto a single site may allow you to preserve one contract while exiting another, rather than surrendering both. Read more about amalgamation and consolidation.
  • Varying your hours — if the issue is the operational burden of your current hours, an opening hours variation may allow you to reduce your commitment without giving up the contract. Read more about opening hours applications.

Wales

The process for voluntary market exit in Wales is governed by the NHS (Pharmaceutical Services) (Wales) Regulations 2020 and involves notification to the relevant local health board. The notice periods and procedural requirements differ from England. TI Pharmacy Consultancy advises on market exit in Wales under the Welsh regulatory framework.

Thinking about closing your pharmacy?

Contact TI Pharmacy Consultancy before taking any steps. We will advise on the regulatory requirements, the notice periods and whether an alternative to market exit might better serve your interests.

Get in touch

Frequently asked questions

The notice period for voluntary removal from the pharmaceutical list is set out in the NHS Regulations and is typically 3 months, though this can vary. Before serving notice, you should ensure that adequate alternative pharmaceutical provision exists in the area, as the ICB may object if your closure would leave a gap in services. TI Pharmacy Consultancy advises on the correct process and timescales before any notice is served.

An NHS pharmacy contract cannot be sold separately from the pharmacy business — it transfers as part of a change of ownership of the pharmacy premises and business. If you are looking to exit the market, selling the pharmacy as a going concern is usually the most commercially sensible route, as the value of the business includes the NHS contract. TI Pharmacy Consultancy advises on the regulatory aspects of pharmacy sales and can assist with the change of ownership application.

The ICB has a duty to ensure that patients have access to pharmaceutical services. When a pharmacy closes, the ICB monitors the impact on local provision and may take steps to ensure alternative services are available. You should notify the ICB and PCSE of your intention to close in good time to allow them to plan for the transition. TI Pharmacy Consultancy advises on the notification process.

For pharmacy owners with more than one premises, consolidating contracts onto a single site is often preferable to market exit — it preserves the value of the NHS contract rather than surrendering it. Consolidation requires ICB approval and is subject to a gap-in-provision assessment. TI Pharmacy Consultancy advises on whether consolidation is viable and manages the application. See our amalgamation and consolidation page for more detail.

Closing a pharmacy involves notifying PCSE and the ICB, serving the correct notice period, ensuring GPhC premises registration is dealt with, managing the controlled drugs register and notifying NHS England and the ICB of the closure date. TI Pharmacy Consultancy advises on the regulatory steps and helps ensure that all notifications are made correctly and in the right order.